This section is intended for patients prescribed Alunbrig. If you are a member of the public click here. If you are a UK healthcare professional click here.

Before starting treatment with Alunbrig  (brigatinib)

Although they will know your medical history, there are some important facts your doctor or nurse should be aware of before you start treatment with Alunbrig.

What do I need to tell my nurse or oncologist before I start, or while I am taking Alunbrig?

Tell your nurse or oncologist about all your medical conditions, including if you have:

  • Lung or breathing problems
  • High blood pressure
  • Slow heartbeat
  • Vision disturbances (such as flashes of light, blurry vision or light hurting your eyes)
  • Muscle problems (such as pain, tenderness or weakness)
  • Pancreas problems
  • Liver problems
  • High blood sugar
  • Kidney problems, or if you are on dialysis
  • An allergy to any of the ingredients of Alunbrig

Pregnancy and fertility:

Alunbrig is not recommended during pregnancy. Effective non-hormonal contraception must be used during treatment and for 4 months after stopping Alunbrig. Men are advised to use effective contraception during treatment and for 3 months after stopping.


Do not breastfeed while on Alunbrig.

Driving and using machines:

Alunbrig may cause visual disturbances, dizziness or tiredness. Do not drive or use machines during treatment if such signs occur.

Alunbrig contains lactose:

If you are intolerant to some sugars, please contact your doctor.

Are you taking other medicines?

Tell your nurse or oncologist about all the medicines you take, including:

  • Prescription medicines
  • Over-the-counter medicines
  • Vitamins
  • Herbal supplements

Please refer to the Patient Information Leaflet (PIL) for a complete list of medical conditions and medicines that may affect your treatment.

Patient Alert Card thumbnail

Patient Alert Card

Carry this card with you at all times and take it with you to any medical appointments you may have. You should present it to any doctors or nurses treating you, even if they are not your usual treating oncologist or lung nurse.

Patient booklet thumbnail

My Patient Booklet

This guide contains information for people taking Alunbrig for the treatment of ALK-positive advanced non-small cell lung cancer (aNSCLC) after previous crizotinib treatment. It also contains the patient alert card.

Download booklet